Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2013 Jun 27;368(26):2530.
doi: 10.1056/NEJMc1305687.

Omalizumab for chronic urticaria

Marcus Maurer, Karin Rosén, Hsin-Ju Hsieh
Comment

Omalizumab for chronic urticaria

Marcus Maurer et al. N Engl J Med. .
No abstract available

PubMed Disclaimer

Comment on

  • Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria.
    Maurer M, Rosén K, Hsieh HJ, Saini S, Grattan C, Gimenéz-Arnau A, Agarwal S, Doyle R, Canvin J, Kaplan A, Casale T. Maurer M, et al. N Engl J Med. 2013 Mar 7;368(10):924-35. doi: 10.1056/NEJMoa1215372. Epub 2013 Feb 24. N Engl J Med. 2013. PMID: 23432142 Clinical Trial.
  • Omalizumab for chronic urticaria.
    Wu K, Long H. Wu K, et al. N Engl J Med. 2013 Jun 27;368(26):2527-8. doi: 10.1056/NEJMc1305687. N Engl J Med. 2013. PMID: 23802530 No abstract available.
  • Omalizumab for chronic urticaria.
    Benelli E, Ventura A. Benelli E, et al. N Engl J Med. 2013 Jun 27;368(26):2528. doi: 10.1056/NEJMc1305687. N Engl J Med. 2013. PMID: 23802531 No abstract available.
  • Omalizumab for chronic urticaria.
    Altman MC, Naimi DR. Altman MC, et al. N Engl J Med. 2013 Jun 27;368(26):2528-30. doi: 10.1056/NEJMc1305687. N Engl J Med. 2013. PMID: 23802532 No abstract available.

Substances

LinkOut - more resources